MOONLAKE IMMUNO (MLTX)
(Delayed Data from NSDQ)
$8.66 USD
+0.23 (2.73%)
Updated Oct 6, 2025 04:00 PM ET
After-Market: $8.77 +0.11 (1.27%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, MoonLake Immunotherapeutics has a market cap of $541.47M, which represents its share price of $8.43 multiplied by its outstanding shares number of 64.23M. As a small-cap company, MLTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MLTX 8.66 +0.23(2.73%)
Will MLTX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for MLTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MLTX
MLTX Stock Gains 18% as Merck Reportedly Eyes Buyout
Wall Street Analysts Think MOONLAKE IMMUNO (MLTX) Could Surge 106.62%: Read This Before Placing a Bet
MLTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MLTX
Top 3 Health Care Stocks That Are Preparing To Pump In Q4
LifeSci Capital Reaffirms Their Buy Rating on MoonLake Immunotherapeutics (MLTX)
Is MLTX building bearish momentum? 1,2,3 Retracement Bearish shows up after soaring 13.0%
Unusually active option classes on open October 3rd
Unusually active option classes on open October 3rd